Abiopharma

Credo Technology Group Holding Ltd Reports Fourth Quarter and Fiscal Year 2026 Financial Results

SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION

Ampco-Pittsburgh Corporation to Present at the East Coast IDEAS Investor Conference on June 10, 2026, in New York

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Fluor Joint Venture Receives Limited Notice to Proceed for Proposed Phase 2 Expansion of LNG Canada Facility

Definium Therapeutics Announces New Employee Inducement Grants

New Era Energy & Digital Strengthens Leadership Team with Appointments of Evan Pierce as Chief Development Officer and Michael Johnson as General Counsel and Chief Compliance Officer

Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference

Sonoco Releases Corporate Sustainability Report Highlighting Progress and Award-Winning Products

Thornburg Income Builder Opportunities Trust Announces Distribution